HandsOn Global Management (HGM)
NSE: HGMBSE: 532761
₹ 39.05 0 (0%)28 Oct, 03:20 pm IST
- Market cap
- ₹ 50 Cr.
- P/E
- 170.2x
- P/B
- 2.49x
- 52-week range
- 38.06 – 81
- ROE
- −10%
- ROCE
- −0.4%
- Dividend yield
- 0%
- Debt / equity
- 1.15
- Sector
- IT - Services
- Industry
- IT Enabled Services
- Listed on
- NSE, BSE
Quick check
The five things to look at first. Open one for more.
Compared with its industry
IT Enabled Services: 107 companies →HandsOn Global Management (HGM) against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)170.2 against a typical 25.2: pricier than most peers (1st = cheapest).96th of 106
- Sales growth−20.6% against a typical +20.8% from a year earlier.73rd of 85
- Profit growth−219.1% against a typical +5.6% from a year earlier.74th of 77
- Share price, 3 months−23.8% against a typical −9.1%.77th of 93
- Size₹ 50.4 Cr. market value against a typical ₹ 206.6 Cr. (1st = largest).73rd of 100
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 17 Sep 2026 | Other business matters | To consider inter alia, matter of strategic investments opportunities. |
| 14 Aug 2026 | Financial Results | To consider and approve inter alia, the financial results for the period ended Jun 30, 2026 |
| 30 May 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2026 and other business matters-request of certain promoters for re-classification of their shareholdings to public category. |
| 14 Feb 2026 | Financial Results | To consider and approve the financial results for the period ended December 31, 2025 |
| 14 Nov 2025 | Financial Results | To consider and approve inter-alia, the financial results for the period ended September 30, 2025 |
| 20 Aug 2025 | Other business matters | To consider a potential acquisition, through its US based wholly owned subsidiary, in Artificial Intelligence(AI)-powered Autonomous Medical Coding Platform in revenue cycle management(RCM) space. |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4 | 4 | 4 | 6 | 6 | 6 | 6 | 14 | 19 | 14 | 13 | 11 |
| Expenses | 4 | 3 | 3 | 5 | 5 | 5 | 4 | 11 | 18 | 17 | 15 | 12 |
| Operating Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | −2 | −2 | −1 |
| OPM % | 16.3% | 16% | 19% | 16.5% | 16.1% | 14.5% | 18.7% | 17.4% | 5.8% | −17% | −16.1% | −10.9% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | −3 | −2 | −2 |
| Tax % | 26.3% | 27.6% | 25.7% | 27.4% | 25.9% | 9.5% | −12.7% | 28.3% | 56.9% | 4.3% | 20.7% | −5.5% |
| Net Profit | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | −3 | −2 | −2 |
| EPS in Rs | 0.58 | 0.5 | 0.64 | 0.62 | 0.64 | 1.05 | 1.05 | 1.37 | 0.4 | −2.48 | −1.71 | −1.64 |
Growth and returns
Compounded yearly rates over each period.
Compounded Sales Growth
- 10 Years
- 15%
- 5 Years
- 44%
- 3 Years
- 70%
- TTM
- 86%
Compounded Profit Growth
- 10 Years
- 7%
- 5 Years
- —
- 3 Years
- —
- TTM
- −232%
Stock Price CAGR
- 10 Years
- −9%
- 5 Years
- −5%
- 3 Years
- −3%
- TTM
- —
Return on Equity
- 10 Years
- −8%
- 5 Years
- 6%
- 3 Years
- 5%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
P/E 170.2xEPS (12 months) ₹ 0.34Median P/E 20.8x
P/E (times)EPS (₹)
Prices are delayed and for information only. Nothing on this page is investment advice.